Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Reformulated EVRA Patch
NCT03274297Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2017
- Primary completion
- May 2018
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ethinyl estradiol + norelgestromin in contraception, sponsored by Janssen Pharmaceutical. Started Sep 2017; status: completed.
02
Drugs
ethinyl estradiol + norelgestromin
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03274297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03274297.